Loading…
CIK 0001776382 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("venbio-partners-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ALUMIS INC | COM | $99.8M | 35.6%Prev: 13.9% | 4,528,408 SH | Increased+1,741,010 SH |
| ALX ONCOLOGY HLDGS INC | COM | $25.8M | 9.2%Prev: 4.9% | 12,884,638 SH | Increased+3,184,713 SH |
| ARTIVA BIOTHERAPEUTICS INC | COM | $3.4M | 1.2%Prev: 2.9% | 531,337 SH | Decreased-667,638 SH |
| HARMONY BIOSCIENCES HLDGS IN | COM | $13.7M | 4.9%Prev: 13.1% | 489,194 SH | Decreased |
| LYELL IMMUNOPHARMA INC | COM | $6.8M | 2.4%Prev: 3.1% | 337,697 SH | Increased-6,764,493 SH |
| PHARVARIS N V | COM | $131.1M | 46.7%Prev: 54.5% | 4,639,304 SH | Increased+350,000 SH |
| 13F-HR |
| 0000905148-26-003741 |
| $519.4M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000905148-25-002929 | $114.8M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0000905148-26-002409 | $280.6M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000905148-25-001748 | $123.6M | View |